DOCK5

Dedicator of cytokinesis protein 5 · Q9H7D0 · DOCK5 on Sugi Atlas →

455 patent compounds predicted against DOCK5, 224 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL21475552 SCHEMBL21475552 1.00 9/20
SCHEMBL21481076 SCHEMBL21481076 1.00 9/20
SCHEMBL21480987 SCHEMBL21480987 0.92 9/20
SCHEMBL21456931 SCHEMBL21456931 1.00 8/20
SCHEMBL21456934 SCHEMBL21456934 1.00 8/20
SCHEMBL21456945 SCHEMBL21456945 1.00 8/20
SCHEMBL21456946 SCHEMBL21456946 1.00 8/20
SCHEMBL21456947 SCHEMBL21456947 1.00 8/20
SCHEMBL21456949 SCHEMBL21456949 1.00 8/20
SCHEMBL21456951 SCHEMBL21456951 1.00 8/20
SCHEMBL21456952 SCHEMBL21456952 1.00 8/20
SCHEMBL21456953 SCHEMBL21456953 1.00 8/20
SCHEMBL21456954 SCHEMBL21456954 1.00 8/20
SCHEMBL21456955 SCHEMBL21456955 1.00 8/20
SCHEMBL21456956 SCHEMBL21456956 1.00 8/20
SCHEMBL21456957 SCHEMBL21456957 1.00 8/20
SCHEMBL21456959 SCHEMBL21456959 1.00 8/20
SCHEMBL21456937 SCHEMBL21456937 0.87 8/20
SCHEMBL21456939 SCHEMBL21456939 0.87 8/20
SCHEMBL21481081 SCHEMBL21481081 0.87 8/20

Clinical trials — most relevant to DOCK5 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old PHASE3NOT_YET_RECRUITING
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment PHASE2/PHASE3RECRUITING
Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency PHASE2ACTIVE_NOT_RECRUITING
Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100 PHASE1/PHASE2COMPLETED
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Identification of Genomic Loci Determining Susceptibility to the Development of High Myopia nanCOMPLETED
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches. nanRECRUITING
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Speech and Short-term Memory Functions in Dyslexia: a Combined MEG and EEG Study nanUNKNOWN
Family Myopia Study nanCOMPLETED
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma nanRECRUITING
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science nanRECRUITING
Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms nanUNKNOWN
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature. nanUNKNOWN
Mapping Disease Pathways for Biliary Atresia nanRECRUITING
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
Ganaxolone Expanded Access Program Compassionate Use nanNO_LONGER_AVAILABLE
Study of the Value of Trio Exome Sequencing in the Etiological Assessment of Specific Non-syndromic Language and Learning Disorders nanRECRUITING
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Identification of an Asthma Susceptibility Gene on 3P nanCOMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome nanRECRUITING
Human Epilepsy Genetics--Neuronal Migration Disorders Study nanRECRUITING
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies nanRECRUITING
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a DOCK5 binder may also engage these)

ProteinNameSimilarity
DOCK2 Dedicator of cytokinesis protein 2 1.000 landscape →
B2RY04 1.000 B2RY04 →
Q8C3J5 1.000 Q8C3J5 →
Q8BUR4 0.999 Q8BUR4 →
Q14185 0.999 Q14185 →
O74925 0.992 O74925 →
Q19555 0.991 Q19555 →
Q9TXI7 0.991 Q9TXI7 →
Q9VRX1 0.991 Q9VRX1 →
Q19954 0.991 Q19954 →
A8WTE8 0.990 A8WTE8 →
Q24314 0.990 Q24314 →
O01763 0.990 O01763 →
Q09743 0.990 Q09743 →
Q8STE5 0.989 Q8STE5 →
Q9STV0 0.989 Q9STV0 →
Q54F23 0.989 Q54F23 →
Q8WUM0 0.989 Q8WUM0 →
Q9W3E1 0.989 Q9W3E1 →
Q750S2 0.988 Q750S2 →
Q9XZ06 0.988 Q9XZ06 →
Q9Y3A3 0.988 Q9Y3A3 →
Q5XG71 0.988 Q5XG71 →
Q9VFB7 0.988 Q9VFB7 →
Q09600 0.988 Q09600 →
Q54K32 0.988 Q54K32 →
Q9VYG1 0.988 Q9VYG1 →
Q8LPK4 0.988 Q8LPK4 →
Q9U2Y2 0.988 Q9U2Y2 →
B4NBB0 0.988 B4NBB0 →